Almaden Genomics and BigOmics collaborate to merge g.nome® with Omics Playground, providing seamless omics data analysis. This integration facilitates end-to-end exploration, with g.nome ensuring traceability and reproducibility in processing, while Omics Playground offers interactive analysis for deeper insights. The partnership aims to democratize omics data analysis, accelerating tertiary analysis and fostering collaboration in biotech and academia.
Almaden Genomics and BigOmics have joined forces to offer comprehensive omics data analysis solutions. Through the collaboration, Omics Playground, developed by BigOmics, integrates seamlessly with g.nome®, Almaden’s cloud-native omics data science platform. This integration enables researchers to conduct end-to-end analysis effortlessly.
g.nome facilitates seamless data processing and analysis, ensuring researchers can explore their findings with complete traceability and reproducibility. On the other hand, Omics Playground serves as a data discovery platform, empowering researchers to delve deeper into their data through interactive analysis, gaining a better understanding of the underlying biology.
David Gascoigne, CEO of Almaden Genomics, emphasized the significance of this integration, stating that it provides researchers with a smooth transition into downstream analysis. The collaboration aims to expedite the journey towards crucial insights by enabling additional tertiary analysis.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Omics Playground, developed by Swiss-based BigOmics, offers scientists an intuitive interface for exploring omics data, featuring interactive visualization and data exploration modules. Combining Omics Playground with g.nome simplifies the process for both data scientists and biologists, particularly in the realm of drug discovery.
Murat Akhmedov, Ph.D., Co-founder and CEO of BigOmics, highlighted the goal of democratizing omics data analysis through this collaboration. By making end-to-end analysis more accessible, the collaboration aims to foster innovation and collaboration within biotech and academic communities, ultimately lowering the barriers to discovery.
Almaden Genomics’ g.nome platform provides researchers with pre-built, transparent, and customizable workflows, enabling quick and easy access to results. This allows scientists to delve deeper into their data with a clear understanding of its origins and significance.
